Resting Heart Rate
0
Pipeline Programs
1
Companies
5
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Heidelberg PharmaGermany - Ladenburg
2 programsCool roofN/A4 trials
Cool roofN/A1 trial
Active Trials
+2 more trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
Heidelberg PharmaCool roof
Heidelberg PharmaCool roof
Heidelberg PharmaCool roof
Heidelberg PharmaCool roof
Heidelberg PharmaCool roof
Clinical Trials (5)
Total enrollment: 5,275 patients across 5 trials
Assessing the Effect of Cool Roofs on Health Using Smartwatches in Colima, Mexico
Start: Apr 2026Est. completion: Sep 2027800 patients
N/ANot Yet Recruiting
Assessing the Effects of Cool Roofs on Indoor Environments and Health in Colima, Mexico
Start: Apr 2026Est. completion: Sep 2027800 patients
N/ANot Yet Recruiting
Assessing the Effect of Cool Roofs on Health Using Smartwatches in Niue
Start: Sep 2024Est. completion: Jan 2026187 patients
N/ACompleted
Assessing the Effects of Cool Roofs on Indoor Environments and Health
Start: Sep 2024Est. completion: Sep 20273,200 patients
N/ARecruiting
Assessing the Effects of Cool Roofs on Indoor Environments and Health in Niue
Start: Sep 2024Est. completion: Jan 2026288 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 5,275 patients
1 companies competing in this space